TMCnet News

Research and Markets: World Cardiomyopathy Therapeutics Pipeline Review, H2 2015 - 17 Companies & 29 Drug Profiles
[December 11, 2015]

Research and Markets: World Cardiomyopathy Therapeutics Pipeline Review, H2 2015 - 17 Companies & 29 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/tjmhvl/cardiomyopathy) has announced the addition of the "Cardiomyopathy - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cardiomyopathy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Array BioPharma Inc.
  • Bioheart, Inc.
  • Gilead Sciences, Inc.
  • Heart Metabolics Limited
  • Hemostemix Ltd
  • Kasiak Research Private Limited
  • miRagen Therapeutics, Inc.
  • MyoKardia, Inc.
  • Neurimmune Holding AG
  • Nyken BV
  • Sanofi
  • Shire Plc
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Private Limited
  • Torrent Pharmaceuticals Limited
  • Vericel Corporation
  • Virocan Therapeutics Private Limited



Drug Profiles

  • ACP-01
  • AdipoCell
  • AmVidcm-008
  • ARRY-797
  • binimetinib
  • CAP-1002
  • Cyndacel-M
  • Drugs for Dilated Cardiomyopathy
  • Drugs to Activate Nrf2 for Diabetic Cardiomyopathy and Metabolic Disorders
  • eleclazine
  • Gene Therapy for Cardiomyopathy
  • Gene Therapy to Activate Smad7 for Hypertensive Cardiomyopathy and Kidney Fibrosis
  • ixmyelocel-T
  • JR-100
  • Mesenchymal Stem Cells
  • MGN-9103
  • Monoclonal Antibodies for Cardiovascular Diseases
  • MYK-461
  • NI-301
  • NYK-1112
  • perhexiline maleate
  • Recombinant Peptide to Agonize GLP-1 for Cardiomyopathy
  • Recombinat Proten to Antagonize Interleukin-1 Receptor for Cardiomyopathy and Ischemia Reperfusion Injury
  • Refacell-DCM (News - Alert)
  • SHP-627
  • Small Molecule for Dilated Cardiomyopathy
  • Stempeucel
  • TRC-120038
  • YS-1402

For more information visit http://www.researchandmarkets.com/research/tjmhvl/cardiomyopathy



[ Back To TMCnet.com's Homepage ]